title: Sodium 18F-Fluoride Bone Scintigraphy in Deep Ocean Diver.
abstract: Sodium ¹⁸F-fluoride (NaF) is a diagnostic marker for new bone formation in bone scintigraphy that was approved by US FDA in 1972 but discontinued in 1984. We report a case of a US naval officer who spent time living and working in an oceanic lab, 205 feet below the surface. Plain skeletal films of femurs 4 years later demonstrate bilateral bone infarcts. Corresponding sodium ¹⁸F-fluoride bone scintigraphy demonstrates low-normal to decreased tracer activity. This rectilinear scan image is of historical interest. Other bone scintigraphic radiotracers used in the past and present will be briefly discussed.
authors.affiliation: From the *Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA; and †Nuclear Medicine Service, Veterans Affairs Medical Center, Atlanta, GA.
authors.forename: Jin T E
authors.initials: JT
authors.lastname: Lim
authors.forename: Valeria M
authors.initials: VM
authors.lastname: Moncayo
authors.forename: Naomi
authors.initials: N
authors.lastname: Alazraki
mesh_terms: D004242:Diving / Q000009:adverse effects*; D005269:Femur / Q000098:blood supply / Q000000981:diagnostic imaging*; D005462:Fluorine Radioisotopes; D006801:Humans; D007238:Infarction / Q000000981:diagnostic imaging* / Q000209:etiology; D008297:Male; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
chemical_list: D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals